TherapeuticsMD, Inc. operates as a healthcare company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The firm also manufactures and distributes branded and...
Not really a household name among investors but well known to the ever growing of shorts. As of March 26th there was a 38% short interest. Despite FDA approval for 3 new drugs sales have been dismal and the company has increased expenditure on sales to tackle the issue, thus driving operating expenses much higher. The price currently sits at $4.57 well below the...
A long set up with a good profit to loss ratio. Stock has previously broken the 200 EMA. Appears to be starting a full-on uptrend. Best of luck.
Inside on the support line of a Bullish Symmetrical Triangle, with 3 FDA approved drugs about to hit the market with massive revenues.
i see strong up movment coming join my friends channel for education contingenttrader.com
FDA Announcement for Tuesday 5/29/18 can see a nice pop past resistances and peak between $8 - $11.50 with correct volume. Short squeeze will be the first step in order to achieve this goal.
Might want to be on your watch list in the morning for a potential chart. Comment if you'd like.